Splenomegaly and erythrocytosis: the impact on patient management in ET
Are you aware of the diagnostic criteria used to differentiate polycythemia vera (PV) from essential thrombocythemia (ET) and primary myelofibrosis (PMF)?
Watch Professor Claire Harrison as she explains how splenomegaly and erythrocytosis can be important for identifying various forms of blood disorder and myeloproliferative neoplasms (MPNs).1, 2
1.Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-405.
2.Thiele J and Kvasnicka HM. The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Curr Hematol Malig Rep. 2009;4(1)33-40.